Loading…

VEGFR-3 signaling in macrophages: friend or foe in disease?

Lymphatic vessels have been increasingly appreciated in the context of immunology not only as passive conduits for immune and cancer cell transport but also as key in local tissue immunomodulation. Targeting lymphatic vessel growth and potential immune regulation often takes advantage of vascular en...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2024, Vol.15, p.1349500
Main Authors: Kannan, Saranya, Rutkowski, Joseph M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c364t-ee192e1bfbeb94421ce4a32bf093c93e2934d4e298895237faeb87cf44f70ec43
container_end_page
container_issue
container_start_page 1349500
container_title Frontiers in immunology
container_volume 15
creator Kannan, Saranya
Rutkowski, Joseph M
description Lymphatic vessels have been increasingly appreciated in the context of immunology not only as passive conduits for immune and cancer cell transport but also as key in local tissue immunomodulation. Targeting lymphatic vessel growth and potential immune regulation often takes advantage of vascular endothelial growth factor receptor-3 (VEGFR-3) signaling to manipulate lymphatic biology. A receptor tyrosine kinase, VEGFR-3, is highly expressed on lymphatic endothelial cells, and its signaling is key in lymphatic growth, development, and survival and, as a result, often considered to be "lymphatic-specific" in adults. A subset of immune cells, notably of the monocyte-derived lineage, have been identified to express VEGFR-3 in tissues from the lung to the gut and in conditions as varied as cancer and chronic kidney disease. These VEGFR-3+ macrophages are highly chemotactic toward the VEGFR-3 ligands VEGF-C and VEGF-D. VEGFR-3 signaling has also been implicated in dictating the plasticity of these cells from pro-inflammatory to anti-inflammatory phenotypes. Conversely, expression may potentially be transient during monocyte differentiation with unknown effects. Macrophages play critically important and varied roles in the onset and resolution of inflammation, tissue remodeling, and vasculogenesis: targeting lymphatic vessel growth and immunomodulation by manipulating VEGFR-3 signaling may thus impact macrophage biology and their impact on disease pathogenesis. This mini review highlights the studies and pathologies in which VEGFR-3+ macrophages have been specifically identified, as well as the activity and polarization changes that macrophage VEGFR-3 signaling may elicit, and affords some conclusions as to the importance of macrophage VEGFR-3 signaling in disease.
doi_str_mv 10.3389/fimmu.2024.1349500
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_33b5a6891c794962a85dccace18276e4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_33b5a6891c794962a85dccace18276e4</doaj_id><sourcerecordid>2955264244</sourcerecordid><originalsourceid>FETCH-LOGICAL-c364t-ee192e1bfbeb94421ce4a32bf093c93e2934d4e298895237faeb87cf44f70ec43</originalsourceid><addsrcrecordid>eNpNUctKBDEQDKKoqD_gQeboZdZJd88jehARHwsLgqjXkMl01sg81mT34N-7465iX6rprq6GKiFOZTZBrNSF8123mkAGNJFIKs-yHXEoi4JSBKDdf_2BOInxI1sXKUTM98UBVlRQDnAort7uHu6fU0yin_em9f088X3SGRuGxbuZc7xMXPDcN8kQEjfwuG18ZBP5-ljsOdNGPtnikXi9v3u5fUxnTw_T25tZarGgZcosFbCsXc21IgJpmQxC7TKFViGDQmpoDVWlcsDSGa6r0joiV2ZsCY_EdKPbDOZDL4LvTPjSg_H6ZzCEuTZh6W3LGrHOTVEpaUtFqgBT5Y21xrKsoCx41DrfaC3C8LniuNSdj5bb1vQ8rKIGledQENBIhQ117UWMgd3fa5npMQP9k4EeM9DbDNZHZ1v9Vd1x83fy6zh-A9Q2gI8</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2955264244</pqid></control><display><type>article</type><title>VEGFR-3 signaling in macrophages: friend or foe in disease?</title><source>PubMed Central</source><creator>Kannan, Saranya ; Rutkowski, Joseph M</creator><creatorcontrib>Kannan, Saranya ; Rutkowski, Joseph M</creatorcontrib><description>Lymphatic vessels have been increasingly appreciated in the context of immunology not only as passive conduits for immune and cancer cell transport but also as key in local tissue immunomodulation. Targeting lymphatic vessel growth and potential immune regulation often takes advantage of vascular endothelial growth factor receptor-3 (VEGFR-3) signaling to manipulate lymphatic biology. A receptor tyrosine kinase, VEGFR-3, is highly expressed on lymphatic endothelial cells, and its signaling is key in lymphatic growth, development, and survival and, as a result, often considered to be "lymphatic-specific" in adults. A subset of immune cells, notably of the monocyte-derived lineage, have been identified to express VEGFR-3 in tissues from the lung to the gut and in conditions as varied as cancer and chronic kidney disease. These VEGFR-3+ macrophages are highly chemotactic toward the VEGFR-3 ligands VEGF-C and VEGF-D. VEGFR-3 signaling has also been implicated in dictating the plasticity of these cells from pro-inflammatory to anti-inflammatory phenotypes. Conversely, expression may potentially be transient during monocyte differentiation with unknown effects. Macrophages play critically important and varied roles in the onset and resolution of inflammation, tissue remodeling, and vasculogenesis: targeting lymphatic vessel growth and immunomodulation by manipulating VEGFR-3 signaling may thus impact macrophage biology and their impact on disease pathogenesis. This mini review highlights the studies and pathologies in which VEGFR-3+ macrophages have been specifically identified, as well as the activity and polarization changes that macrophage VEGFR-3 signaling may elicit, and affords some conclusions as to the importance of macrophage VEGFR-3 signaling in disease.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2024.1349500</identifier><identifier>PMID: 38464522</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Endothelial Cells - metabolism ; FLT4/VEGFR3 ; lymphangiogenesis ; Lymphangiogenesis - physiology ; M1 macrophage ; M2 macrophage ; Macrophages - metabolism ; monocyte ; Vascular Endothelial Growth Factor A - metabolism ; Vascular Endothelial Growth Factor Receptor-3 - metabolism ; VEGFC/D-VEGFR3/NRP2 axis</subject><ispartof>Frontiers in immunology, 2024, Vol.15, p.1349500</ispartof><rights>Copyright © 2024 Kannan and Rutkowski.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c364t-ee192e1bfbeb94421ce4a32bf093c93e2934d4e298895237faeb87cf44f70ec43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4023,27922,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38464522$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kannan, Saranya</creatorcontrib><creatorcontrib>Rutkowski, Joseph M</creatorcontrib><title>VEGFR-3 signaling in macrophages: friend or foe in disease?</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Lymphatic vessels have been increasingly appreciated in the context of immunology not only as passive conduits for immune and cancer cell transport but also as key in local tissue immunomodulation. Targeting lymphatic vessel growth and potential immune regulation often takes advantage of vascular endothelial growth factor receptor-3 (VEGFR-3) signaling to manipulate lymphatic biology. A receptor tyrosine kinase, VEGFR-3, is highly expressed on lymphatic endothelial cells, and its signaling is key in lymphatic growth, development, and survival and, as a result, often considered to be "lymphatic-specific" in adults. A subset of immune cells, notably of the monocyte-derived lineage, have been identified to express VEGFR-3 in tissues from the lung to the gut and in conditions as varied as cancer and chronic kidney disease. These VEGFR-3+ macrophages are highly chemotactic toward the VEGFR-3 ligands VEGF-C and VEGF-D. VEGFR-3 signaling has also been implicated in dictating the plasticity of these cells from pro-inflammatory to anti-inflammatory phenotypes. Conversely, expression may potentially be transient during monocyte differentiation with unknown effects. Macrophages play critically important and varied roles in the onset and resolution of inflammation, tissue remodeling, and vasculogenesis: targeting lymphatic vessel growth and immunomodulation by manipulating VEGFR-3 signaling may thus impact macrophage biology and their impact on disease pathogenesis. This mini review highlights the studies and pathologies in which VEGFR-3+ macrophages have been specifically identified, as well as the activity and polarization changes that macrophage VEGFR-3 signaling may elicit, and affords some conclusions as to the importance of macrophage VEGFR-3 signaling in disease.</description><subject>Endothelial Cells - metabolism</subject><subject>FLT4/VEGFR3</subject><subject>lymphangiogenesis</subject><subject>Lymphangiogenesis - physiology</subject><subject>M1 macrophage</subject><subject>M2 macrophage</subject><subject>Macrophages - metabolism</subject><subject>monocyte</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><subject>Vascular Endothelial Growth Factor Receptor-3 - metabolism</subject><subject>VEGFC/D-VEGFR3/NRP2 axis</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpNUctKBDEQDKKoqD_gQeboZdZJd88jehARHwsLgqjXkMl01sg81mT34N-7465iX6rprq6GKiFOZTZBrNSF8123mkAGNJFIKs-yHXEoi4JSBKDdf_2BOInxI1sXKUTM98UBVlRQDnAort7uHu6fU0yin_em9f088X3SGRuGxbuZc7xMXPDcN8kQEjfwuG18ZBP5-ljsOdNGPtnikXi9v3u5fUxnTw_T25tZarGgZcosFbCsXc21IgJpmQxC7TKFViGDQmpoDVWlcsDSGa6r0joiV2ZsCY_EdKPbDOZDL4LvTPjSg_H6ZzCEuTZh6W3LGrHOTVEpaUtFqgBT5Y21xrKsoCx41DrfaC3C8LniuNSdj5bb1vQ8rKIGledQENBIhQ117UWMgd3fa5npMQP9k4EeM9DbDNZHZ1v9Vd1x83fy6zh-A9Q2gI8</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>Kannan, Saranya</creator><creator>Rutkowski, Joseph M</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>2024</creationdate><title>VEGFR-3 signaling in macrophages: friend or foe in disease?</title><author>Kannan, Saranya ; Rutkowski, Joseph M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c364t-ee192e1bfbeb94421ce4a32bf093c93e2934d4e298895237faeb87cf44f70ec43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Endothelial Cells - metabolism</topic><topic>FLT4/VEGFR3</topic><topic>lymphangiogenesis</topic><topic>Lymphangiogenesis - physiology</topic><topic>M1 macrophage</topic><topic>M2 macrophage</topic><topic>Macrophages - metabolism</topic><topic>monocyte</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><topic>Vascular Endothelial Growth Factor Receptor-3 - metabolism</topic><topic>VEGFC/D-VEGFR3/NRP2 axis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kannan, Saranya</creatorcontrib><creatorcontrib>Rutkowski, Joseph M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kannan, Saranya</au><au>Rutkowski, Joseph M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>VEGFR-3 signaling in macrophages: friend or foe in disease?</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2024</date><risdate>2024</risdate><volume>15</volume><spage>1349500</spage><pages>1349500-</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Lymphatic vessels have been increasingly appreciated in the context of immunology not only as passive conduits for immune and cancer cell transport but also as key in local tissue immunomodulation. Targeting lymphatic vessel growth and potential immune regulation often takes advantage of vascular endothelial growth factor receptor-3 (VEGFR-3) signaling to manipulate lymphatic biology. A receptor tyrosine kinase, VEGFR-3, is highly expressed on lymphatic endothelial cells, and its signaling is key in lymphatic growth, development, and survival and, as a result, often considered to be "lymphatic-specific" in adults. A subset of immune cells, notably of the monocyte-derived lineage, have been identified to express VEGFR-3 in tissues from the lung to the gut and in conditions as varied as cancer and chronic kidney disease. These VEGFR-3+ macrophages are highly chemotactic toward the VEGFR-3 ligands VEGF-C and VEGF-D. VEGFR-3 signaling has also been implicated in dictating the plasticity of these cells from pro-inflammatory to anti-inflammatory phenotypes. Conversely, expression may potentially be transient during monocyte differentiation with unknown effects. Macrophages play critically important and varied roles in the onset and resolution of inflammation, tissue remodeling, and vasculogenesis: targeting lymphatic vessel growth and immunomodulation by manipulating VEGFR-3 signaling may thus impact macrophage biology and their impact on disease pathogenesis. This mini review highlights the studies and pathologies in which VEGFR-3+ macrophages have been specifically identified, as well as the activity and polarization changes that macrophage VEGFR-3 signaling may elicit, and affords some conclusions as to the importance of macrophage VEGFR-3 signaling in disease.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>38464522</pmid><doi>10.3389/fimmu.2024.1349500</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-3224
ispartof Frontiers in immunology, 2024, Vol.15, p.1349500
issn 1664-3224
1664-3224
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_33b5a6891c794962a85dccace18276e4
source PubMed Central
subjects Endothelial Cells - metabolism
FLT4/VEGFR3
lymphangiogenesis
Lymphangiogenesis - physiology
M1 macrophage
M2 macrophage
Macrophages - metabolism
monocyte
Vascular Endothelial Growth Factor A - metabolism
Vascular Endothelial Growth Factor Receptor-3 - metabolism
VEGFC/D-VEGFR3/NRP2 axis
title VEGFR-3 signaling in macrophages: friend or foe in disease?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T17%3A39%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=VEGFR-3%20signaling%20in%20macrophages:%20friend%20or%20foe%20in%20disease?&rft.jtitle=Frontiers%20in%20immunology&rft.au=Kannan,%20Saranya&rft.date=2024&rft.volume=15&rft.spage=1349500&rft.pages=1349500-&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2024.1349500&rft_dat=%3Cproquest_doaj_%3E2955264244%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c364t-ee192e1bfbeb94421ce4a32bf093c93e2934d4e298895237faeb87cf44f70ec43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2955264244&rft_id=info:pmid/38464522&rfr_iscdi=true